Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2001 | 09-2001 | 07-2001 | 06-2001 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 761 | -6,968 | 556 | -4,823 | 180 |
| Depreciation Amortization | 597 | 389 | 422 | 262 | 214 |
| Accounts receivable | -898 | 47 | -816 | 49 | N/A |
| Accounts payable and accrued liabilities | -80 | -278 | 556 | -422 | N/A |
| Other Working Capital | -605 | 63 | -586 | -274 | -486 |
| Other Operating Activity | 978 | 1,010 | 260 | 1,048 | 0 |
| Operating Cash Flow | $753 | $-5,737 | $392 | $-4,160 | $-92 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,220 | N/A | -2,401 | N/A |
| PPE Investments | -681 | N/A | -359 | N/A | -80 |
| Purchase Of Investment | N/A | -22 | N/A | -22 | N/A |
| Sale Of Investment | N/A | 4,613 | N/A | 4,657 | N/A |
| Purchase Sale Intangibles | N/A | -100 | N/A | -67 | N/A |
| Other Investing Activity | 0 | -100 | 0 | -67 | 0 |
| Investing Cash Flow | $-681 | $3,271 | $-359 | $2,167 | $-80 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | N/A | 500 | N/A | N/A |
| Debt Repayment | -730 | N/A | -513 | N/A | 294 |
| Common Stock Issued | N/A | 2,123 | N/A | 1,220 | N/A |
| Common Stock Repurchased | 0 | -519 | 0 | -363 | N/A |
| Financing Cash Flow | $-230 | $1,604 | $-13 | $857 | $294 |
| Beginning Cash Position | 1,077 | 3,721 | 1,077 | 3,721 | 1,077 |
| End Cash Position | 919 | 2,859 | 1,097 | 2,585 | 1,199 |
| Net Cash Flow | $-158 | $-862 | $20 | $-1,136 | $122 |
| Free Cash Flow | |||||
| Operating Cash Flow | 753 | -5,737 | 392 | -4,160 | -92 |
| Capital Expenditure | -681 | N/A | -359 | N/A | -80 |
| Free Cash Flow | 72 | -5,737 | 33 | -4,160 | -172 |